These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32011514)

  • 1. Myopathy after rapid correction of hyperthyroidism: A case report and review of literature.
    Lu R; Wang H; Hong T; Gao H
    Medicine (Baltimore); 2020 Jan; 99(3):e18878. PubMed ID: 32011514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathy Associated with Treatment of Graves' Disease.
    Ji YK; Kim SH
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report.
    Li Q; Liu Y; Zhang Q; Tian H; Li J; Li S
    Medicine (Baltimore); 2017 Jul; 96(30):e7591. PubMed ID: 28746208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum creatine kinase induced by anti-thyroid drugs: Two case reports and a literature review.
    Si Y; Su F; Wu H; Shen C
    Int J Clin Pharmacol Ther; 2022 Nov; 60(11):492-498. PubMed ID: 36052652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum creatine kinase during methimazole treatment of Graves disease in a 13-year-old girl and a literature review of similar cases.
    Kim H; Kim J; Huh R; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):106-9. PubMed ID: 26191516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
    Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual evolution of thyroid function after therapeutic plasma exchange in Graves' disease with cholestatic jaundice: A case report.
    Jin Y; Feng X; Ni H
    Medicine (Baltimore); 2024 Feb; 103(8):e37074. PubMed ID: 38394504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.
    Cheng Y; Sun Z; Zhong D; Ren L; Yang H
    Medicine (Baltimore); 2020 Oct; 99(43):e22898. PubMed ID: 33120839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THERAPEUTIC EFFECTS OF COMBINATION REGIMENS INCLUDING METHIMAZOLE ON GRAVES HYPERTHYROIDISM: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
    Wang M; Yu Y
    Endocr Pract; 2020 Jun; 26(6):675-687. PubMed ID: 32160045
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of serum creatine kinase in response to medical treatment of Graves' disease in children.
    Mizuno H; Sugiyama Y; Nishi Y; Ueda N; Ohro Y; Togari H
    Acta Paediatr; 2006 Feb; 95(2):243-5. PubMed ID: 16449033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
    Azizi F; Abdi H; Amouzegar A
    BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and early effectiveness of methimazole in patients with graves' hyperthyroidism-related severe hepatic dysfunction.
    Li C; Wang KL; Hu JH; Su HB
    Scand J Gastroenterol; 2023; 58(12):1514-1522. PubMed ID: 37545358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.